Safety, tolerance, and efficacy of adenosine as an additive to blood cardioplegia in humans during corona, artery bypass surgery

American Journal of Cardiology

Volumn 79, Issue 12 A, 1997, Pages 38-43

  Mentzer Jr , Robert M ^a,b   Rahko, Peter S ^a,b   Molina Viamonte, Victor ^a,b   Canver, Charles C ^a,b   Chopra, Paramjeet S ^a,b   Love, Robert B ^a,b   Cook, Thomas D ^a,b   Hegge, Julia O ^a,b   Lasley, Robert D ^a,b  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMRINONE; CARDIAC AGENT; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HYPOXANTHINE; INOSINE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PLACEBO;

CARDIOPLEGIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HEART PROTECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STUNNED HEART MUSCLE;

ADENOSINE; ADOLESCENT; CARDIOPLEGIC SOLUTIONS; CARDIOVASCULAR AGENTS; CORONARY ARTERY BYPASS; DOPAMINE; DRUG TOLERANCE; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; HYPOXANTHINE; INOSINE; MALE; MYOCARDIAL STUNNING; NITROGLYCERIN; SAFETY; VASODILATOR AGENTS;

EID: 0343554724     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00262-2     Document Type: Conference Paper

References (20)

1. Belardinelli L, Shryock JC, Song Y, Wang D, Srinivas M. Ionic basis of the electrophysiological actions of adenosine on cardiomyocytes. FASEB J. 9:1995;359-365.
2. 1 adenosine receptors in rabbit heart. Circulation. 84:1994;350-356.
3. 1 receptor mechanism. Am J Physiol. 263:1992;H1460-5.
4. Randhawa MPS Jr, Lasley RD, Mentzer RM Jr. Salutary effects of exogenous adenosine on canine myocardial stunning in vivo. J Thorac Cardiovasc Surg. 110:1995;63-74.
5. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. Effect of adenosine on myocardial "stunning" in the dog. Circ Res. 76:1995;82-94.
6. Mentzer RM Jr, Rahko PS, Canver CC, Chopra PS, Love RB, Cook TD, Hegge JO, Lasley RD. Adenosine reduces postbypass transfusion requirements in humans after heart surgery. Ann Surgery. 224:1996;523-529.
7. 1 receptor mediated protection of the ischemic rat heart. J Mol Cell Cardiol. 25:1993;815-821.
8. 1 receptor system. Cardiovasc Res. 27:1993;28-35.
9. Zhou Z, Bünger R, Lasley RD, Hegge JO, Mentzer RM Jr. Adenosine pretreatment increases cytosolic phosphorylation potential and attenuates postischemic cardiac dysfunction in swine. Surg Forum. 44:1993;249-252.
10. Cronstein BN, Kramer SB, Weissmann G, Hirschhorn R. Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exper Med. 158:1983;1160-1177.
11. Owall A, Ehrenberg J, Brodin LA, Juhlin-Dannfelt A, Sollevi A. Effects of low-dose adenosine on myocardial performance after coronary artery bypass surgery. Acta Anaesthesiol Scand. 37:1993;140-148.
12. Fullerton DA, Jones SD, Grover FL, McIntyre RC Jr. Adenosine effectively controls pulmonary hypertension after cardiac operations. Ann Thorac Surg. 61:1996;1118-1123.
13. Lee HT, Lafaro RJ, Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Cardiac Surg. 10:1995;665-676.
14. Fremes SE, Levy SL, Christakis GT, Walker SE, Iazetta J, Mallidi HR, Federelituv R, Deemar KA, Cohen EA, Wong BI, Goldman BS. Phase 1 human trial of adenosine-potassium cardiolplegia. Circulation. 94:((suppl II)):1996;370-375.
15. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr. The effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Am J Physiol. 269:1995;H1460-H1466.
16. Lasley RD, Noble MA, Konyn PJ, Mentzer RM Jr. Different effects of an adenosine A(1) analogue and ischemic preconditioning in isolated rabbit hearts. Ann Thorac Surg. 60:1995;1698-1703.
17. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
18. Murry CE, Richard VJ, Reimer KA, Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res. 66:1990;913-931.
19. Perrault LP, Menasche P, Bel A, Dechaumaray T, Peynet J, Mondry A, Olivero P, Emanoilravier R, Moalic JM. Ischemic preconditioning in cardiac surgery - a word of caution. J Thorac Cardiovasc Surg. 112:1996;1378-1386.
20. Ovize M, Przyklenk K, Hale SL, Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation. 85:1992;2247-2254.